Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan



  TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin
               Approval for GliderXtreme PTA Catheter in Japan

PR Newswire

PLEASANTON, Calif. and SINGAPORE, Nov. 19, 2013

PLEASANTON, Calif. and SINGAPORE, Nov. 19, 2013 /PRNewswire/ -- TriReme
Medical, LLC. announced today that its Japanese partner, Century Medical, Inc.
(CMI), has received Shonin approval for the GliderXtreme™ PTA catheter for the
treatment of peripheral arterial blockages, a widespread disease impacting
over 200 million people worldwide^1. With its low-profile nitinol shaft and
proprietary "slide-lock" design, GliderXtreme™ is designed to address complex
lesions in the peripheral vasculature. The innovative features of
GliderXtreme™ produce a balloon catheter with exceptional pushability and
crossability, providing physicians with the confidence needed to begin and
finish even the toughest cases.

"Peripheral arterial disease is a growing health care concern in Asia.
GliderXtreme™ was custom designed to meet the clinical needs and exacting
standards of the Japanese marketplace. We are proud to receive this regulatory
approval," stated Eitan Konstantino PhD, President and CEO of TriReme. "This
milestone represents yet another step in the Asia-focused expansion strategy
of TriReme."

"Representing the latest in peripheral balloon technology, GliderXtreme™ will
enable Japanese physicians to treat complex lesions both above and below the
knee," explained Akira Hoshino, President and CEO of CMI. "This is the second
product approved as a result of our collaboration with TriReme Medical."

About TriReme
Based in Pleasanton, California, TriReme Medical, LLC is a wholly-owned
subsidiary of the Singapore based QT Vascular, Ltd. TriReme is dedicated to
the development, manufacturing, and commercialization of next generation
percutaneous devices for the treatment of complex coronary and peripheral
arterial disease.

About Century Medical
Based in Tokyo, Japan, Century Medical, Inc. is a $140 million subsidiary
company of ITOCHU Corporation (TSE: ITC) a $115 billion international trading
company. Century Medical, Inc., with approx. 300 employees, has a 38 year
experience specializing in the importation, sale and marketing of advanced
single use and implantable medical devices.

^1 Comparison of global estimates of prevalence and risk factors for
peripheral artery disease in 2000 and 2010: a systematic review and analysis;
Fowkes et al., The Lancet, Vol 382 October 19, 2013

SOURCE TriReme Medical, Inc.

Contact: TriReme Medical Inc., +1-925-931-1300, info@trirememedical.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement